Remap Consulting

remapconsulting.com/who-we-are/join-our-team/

Stand 30

Remap Consulting is a specialist pharmaceutical pricing, reimbursement and market access consultancy offering an integrated, evidence-based approach to optimising price and patient access for our client’s products. We work with a broad range of global clients, from top 10 pharma through to small start-up organisations, on a diverse range of business-critical projects and product launches.

We work with people responsible for the pricing and reimbursement of pharmaceuticals products who are asking themselves:

What is the optimal price for our pharmaceutical product?

Have we got the right evidence to support pricing and market access at launch?

Do we have the right training capabilities in house to secure pricing and reimbursement?

What is the pricing and market access potential for our business development opportunities?

Departments of Interest: Bioengineering | Chemistry | Medicine

Roche

www.roche.co.uk

Stand 5

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases, and make a sustainable contribution to society. The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2020 employed more than 100,000 people worldwide. In 2021, Roche invested CHF 13.7 billion in R&D.

Departments of Interest: Life Sciences | Medicine

Scitaris GmbH & Co.KG

scitaris.com

Stand 13

We are a consulting firm consisting of passionate scientific minds working with pharma and biotech companies - helping them bring drugs to the market that make meaningful changes to patients’ lives. Our work is focused on various aspects of R&D strategy, science-driven screens to identify the most suitable drug in-licensing opportunities to fit every individual client’s capabilities and goals, as well as reviewing scientific and clinical data, experiments, statistical assumptions, and thus power, estimating its probability of success. All this put into context generates key insights for our clients.

OUR FIRM’S VALUES

• Promote, support and value individual, and thus collective, brilliance – this is embodied by the belief that a collective group of strong minds are greater than the sum of the individuals

• Provide an open & empowering work environment that values innovative ideas, social collaboration and continuous individual development, all with a reasonable work-life balance

• Generating engaging, challenging & impactful consulting work in the biopharma R&D space with the deliverables pivoted around scientific depth leading to unique strategic insights.

Departments of Interest: Life Sciences | Medicine

Sony Group Corporation

www.sony.com/en

Stand 29

Sony was established by founders who shared a dream and a strong will to enrich people’s lives through the power of technology. From our founders’ dreams and aspirations, Sony has grown over the years connecting more people with their dreams.

Sony runs a diverse portfolio of businesses from Electronic Business to Music, Movies, and Entertainment, all of which center around “People”. Talents from all over the world have been playing critical roles to make this happen, and will continue to in light of our journey ahead.

Departments of Interest: Computing